A Japanese subsidiary of a global pharmaceutical company with over 150 years of history. The company has a main product that combines medical devices and pharmaceuticals, and its business has been expanding every year since the expansion of the main product's indications in 2015. It achieved record profits in 2023 and 2024, and its business is expanding favorably. In 2025, in addition to expanding the main product, new drug development is also progressing.
応募資格:
Experience launching pharmaceutical or medical device products
